| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA697851 | F | Inhibitory concentration against Human Jurkat T cells | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
| 2. | ALA697852 | F | Inhibitory concentration against Human Jurkat T cells | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
| 3. | ALA697853 | F | IC80 concentrations of the compounds were used in determining the inhibition of RNA synthesis using Jurkat T cells. | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
| 4. | ALA697854 | F | IC80 concentrations of the compounds were used in determining the inhibition of protein synthesis using Jurkat T cells. | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
| 5. | ALA877842 | F | GI50 was given In vitro as +50% percent growth (PG), measured as concentration of compound required to inhibit disease oriented human tumor cell line panels | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
| 6. | ALA698202 | F | GI50 was given In vitro as +50% percent growth (PG), measured as concentration of compound required to inhibit disease oriented human tumor cell line panels; Value ranges from 0.02->100 | Homo sapiens | 2 | cell-based format | Scientific Literature | ||
| 7. | ALA698203 | F | GI50 was given In vitro as +50% percent growth (PG), measured as concentration of compound required to inhibit disease oriented human tumor cell line panels; Value ranges from 0.060->100 | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
| 8. | ALA698204 | F | GI50 was given In vitro as +50% percent growth (PG), measured as concentration of compound required to inhibit disease oriented human tumor cell line panels; Value ranges from 0.19->100 | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
| 9. | ALA696891 | F | GI50 was given In vitro as +50% percent growth (PG), measured as concentration of compound required to inhibit disease oriented human tumor cell line panels; Value ranges from 0.22-52.48 | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
| 10. | ALA699208 | F | GI50 was given In vitro as +50% percent growth (PG), measured as concentration of compound required to inhibit disease oriented human tumor cell line panels; Value ranges from 0.23-29.5 | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
| 11. | ALA699209 | F | GI50 was given In vitro as +50% percent growth (PG), measured as concentration of compound required to inhibit disease oriented human tumor cell line panels; Value ranges from 0.23->100 | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
| 12. | ALA699210 | F | GI50 was given In vitro as +50% percent growth (PG), measured as concentration of compound required to inhibit disease oriented human tumor cell line panels; Value ranges from 0.32-2 | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
| 13. | ALA698747 | F | GI50 was given In vitro as +50% percent growth (PG), measured as concentration of compound required to inhibit disease oriented human tumor cell line panels; Value ranges from 0.38->100 | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
| 14. | ALA698748 | F | GI50 was given In vitro as +50% percent growth (PG), measured as concentration of compound required to inhibit disease oriented human tumor cell line panels; Value ranges from 0.43->100 | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
| 15. | ALA698749 | F | GI50 was given In vitro as +50% percent growth (PG), measured as concentration of compound required to inhibit disease oriented human tumor cell line panels; Value ranges from 0.51-12.88 | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
| 16. | ALA698750 | F | GI50 was given In vitro as +50% percent growth (PG), measured as concentration of compound required to inhibit disease oriented human tumor cell line panels; Value ranges from 0.62-2.95 | Homo sapiens | 2 | cell-based format | Scientific Literature | ||
| 17. | ALA698751 | F | GI50 was given In vitro as +50% percent growth (PG), measured as concentration of compound required to inhibit disease oriented human tumor cell line panels; Value ranges from 1.38-15.14 | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
| 18. | ALA698752 | F | GI50 was given In vitro as +50% percent growth (PG), measured as concentration of compound required to inhibit disease oriented human tumor cell line panels;Value ranges from 0.06->100 | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
| 19. | ALA698753 | F | GI50 was given in vitro as +50% percent growth (PG), measured as concentration of compound required to inhibit disease oriented human tumor cell line panels; Value ranges from 1.55-16.6 | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
| 20. | ALA698754 | F | GI50 was given in vitro as +50% percent growth (PG), measured as concentration of compound required to inhibit disease oriented human tumor cell line panels; Value ranges from 1.58-11.22 | Homo sapiens | 1 | cell-based format | Scientific Literature |
The page will load shortly, Thanks for your patience!